A word of caution regarding pioglitazone

J Pak Med Assoc. 2017 Jan;67(1):153.
No abstract available

MeSH terms

  • Diabetes Mellitus, Type 2 / drug therapy
  • Humans
  • Hypoglycemic Agents / adverse effects*
  • Hypoglycemic Agents / therapeutic use
  • Pakistan
  • Patient Safety
  • Pioglitazone / adverse effects*
  • Pioglitazone / therapeutic use
  • Urinary Bladder Neoplasms* / chemically induced
  • Urinary Bladder Neoplasms* / epidemiology

Substances

  • Hypoglycemic Agents
  • Pioglitazone